Sagacious research newsletter-16th sep-2013

© 2007 - 2013 Sagacious Research. All Rights Reserved.
www.sagaciousresearch.com
Since many years, IP-related insurance products and services were available in the
market. Yet, unfortunately the top management of almost all companies was not
opting for this extremely valuable protection. Of all company assets, 60% are
intangible, including Intellectual Property, but companies don’t know what they
should be doing with it. As such, IP insurance availability stayed static. Now that the
CEO’s and senior management of companies are becoming more and more aware of
IP risk and the significant exposures it creates, if insurance industry advise clients on
right insurance options and educate the market, IP insurance will only see upwards.
Primarily, intellectual property is challenging to insure as:
• It is difficult to place a value on intangible property
• Rapid changes are occurring in exposures as new technology develops
quickly and continuously
• People are unaware that why they need a specific IP policy and
believe that their commercial general liability (CGL) policies for
IP are adequate.
The dynamic field of Intellectual Property has been dramatically changing and
looking at the current trend, it is quite evident that small yet complicated niche of IP
insurance is certainly emerging as an effective deterrent to patent assertion entities
(PAEs) or patent trolls who sue companies for the sole purpose of extracting licensing
fees. It is, thus, of immense interest to small, medium-sized and even large firms and
their CEO’s who find that there is lot of risk associated with their Intellectual
Propertyand wish to protect their ideas or company trade secrets from infringement
lawsuits. IP remains an important part of a company’s value whether or not one
realizes. It’s in product packaging via design patents and trade dress; in recipes via
trade secrets and utility patents; & in marketing being protected by copyrights.
S A G A C I O U S
U P D A T E S
Sagacious Research
Sponsors in CIPA 2013
Sagacious Research extends
sponsorship to Chartered
Institute of Patent Attorney’s
Annual Congress. As sponsors,
Mr. Anant Kataria, Director-
Research & Ms. Parul Sharma
shall be representing Sagacious
Research at the 2 days
conference being held at
Lancaster London Hotel, London
from 2nd October, 2013 to 4th
October, 2013.
Rising Importance of IP Insurance for
CEO’s Indicates Changing IP Trends
That the CEO’s and senior management of
companies are becoming more and more aware of
IP risk and the significant exposures it creates, if
insurance industry advise clients on right insurance
options and educate the market, IP insurance will
only see upwards.
Vol- 4, Date: 16th September, 2013
G E N E R A L N E W S
Follow Us at:
We Believe in Building
Trust…

As such, there has definitely been an increase in demand and submissions for IP insurance i.e. driven by realization of the economic
importance of IP and the fact that the consumers, the insurance industry and IP law professionals are now quite well-equipped & better
educated regarding the shortcomings of not-so-specific insurance policies.
Earlier, Intellectual property (IP) insurance was not mostly understood and this was unfortunate because many clients could practically
benefit from it. However, the fact is that IP insurance is the most logical and economical choice to ensure that the means are available
with the company to fund the high cost and consequences of IP litigation. Now-a-days, IP of all kinds can be covered, including
trademarks, copyrights, trade secrets, and patents. In fact, there are some IP insurance policies that allows the client to select the
litigating counsel, or that, in addition to providing coverage for the defense of infringement claims, also covers for enforcement actions
against alleged infringers. IP insurance policies for getting reimbursement of IP value reduction due to adverse legal proceedings are
also available.
Having said that above, it is a must that IP-specific insurance should be made a critical part of any company’s risk management plan. IP
lawsuits filed in the USA have dramatically rose. There were 5,189 patent actions recorded in 2012, the highest ever and an increase of
29% over 2011 cases. So, IP risk mitigation is now-a-days essential to protect the overall financial strength of companies and to ensure
that minimal protection is in place for this potentially devastating threat.
Then, the patented neem extract is expected to turn into a drug if it is proved that it has no toxic effects. The glycoprotein formulation
made from neem extract has been successfully tested on animals wherein it helped in normalizing the micro-environment around the
tumour without any side-effects. In case of humans, it will work on a rather simple principle that cancer patients generally have weak
Indian Scientists Patented “Neem Extract” That Fights Cancer
Chittaranjan National Cancer Research Institute (CNCRI), Kolkata has patented a
neem extract which strengthens the immune system and helps in fighting cance
A team of scientists, led by Rathindranath Baral at Chittaranjan National
Cancer Research Institute (CNCRI), Kolkata has patented a neem extract
which strengthens the immune system and helps in fighting cancer. They were
assisted by 22 researchers and PhD students of CNCRI, Bose Institute and
Burdwan University.is about 70%. The research on neem extract, bio-
chemically a glycoprotein, lasted almost seven years and the last stage clinical
trials will commence in end of this year once clearance from the Drug
Controller of India is received.
S O M E O T H E R T O P N E W S I N T H I S C A T E G O R Y:
A Window to Innovation & Patent .
Read: http://ow.ly/oTtDE
Trademark Law & Sports Industry, An Overview.
Read: http://ow.ly/oTtJA
What to Consider Before Sending Patent Letters to Potential Infringer.
Read: http://ow.ly/oTu51
How Website Makes Seeking a Patent More Affordable?
Read: http://ow.ly/oTubk
An Article Guiding Innovators on How to Benefit From Their Inventions.
Read: http://ow.ly/opOzP
L I F E S C I E N C E S

immunity and for curing cancer, immunity needs to be strengthened. It will thereby slow down the growth of cancerous tumours by
triggering interaction between the cells.
CNCRI might approach pharmaceutical companies for producing the drug once its subsequent commercial pathway is set after the Drug
Controller’s clearance.
The neem extract will not be effective as a one-time vaccine as cancerous growths could vary according to the place of occurrence.
However, it could be used as a therapeutic vaccine once cancer has struck. The neem extract patent is indeed a breakthrough and quite
encouraging for the scientists researching finding some effective ayurvedic cancer remedies. However, it is equally important that the
resultant drug is cost-effective and non-toxic for its widespread commercial use.
It is apt if we refer to AAT as the key product of plasma-products industry that is growing at about 10% annually and that already has
$15 billion market.
Earlier, conventional blood donations and plasmapheresis process was used to extract plasma. Though these processes were reliable,
they still needed improvisation to increase the yield of these essential plasma proteins. The current methods of AAT production could
not meet the demand for AAT i.e. created by increasing number of clinical indications and growing number of patients and the lacuna
remained.
The scenario in this constantly evolving industry is now going to change with a new patented plasma extraction process devised by
Plasma Technologies LLC. It is anticipated that company’s technology and patented extraction process will possibly meet the current as
well as the future AAT demand globally by substantially increasing the yield of alpha-1 antitrypsin (AAT) and intravenous immune
globulin (IVIG) besides making possible the extraction of several additional therapeutically useful plasma proteins. This technology
certainly has the potential to change the fundamentals of the economics of blood plasma fractionation. When Plasma Technologies LLC,
a plasma biologics technology company commercializes its patented extraction process, it is expected to reap huge profits. It recently
was awarded the US patent #8,293,242, entitled “Ultra-High Yield of Alpha-1 Antitrypsin.”
Growth in the demand for AAT is primarily attributed to the growing number of diseases, in general, and the statistical revelations that
shows existence of at least 150,000 people with AAT deficiency in North America and Europe though less than 10k receive AAT therapy,
which is lifelong and involves weekly injections of AAT. Besides that, there are many patients of genetic AAT deficiency disorder living
with fatal damages to their lung, liver, pancreatic tissues & pulmonary emphysema. Also, AAT administration in non-deficient
individuals also interfere with progression of fatal diseases such as Diabetes (type 1 & 2), acute myocardial infarction, inflammatory
bowel disease, cystic fibrosis, graft vs. host disease, stroke, Alzheimer’s disease, vasculitis, organ transplantation and multiple sclerosis.
AAT can be supplied in requisite volumes to meet current and future demand through the adoption by company’s proprietary extraction
process by pharmaceutical manufacturers, wherein following steps are involved:
1) Salt precipitation from plasma,
2) Subsequent salt removal by diafiltration and
3) Final purification via affinity and ion exchange chromatography
The aim, however, shall be to increase the supply of AAT and develop new low-cost genetic tests to benefit maximum patients from AAT
therapy. The patented plasma extraction process and technology will not expire until November 2030. Patents for plasma
extraction process have also been filed in major patent jurisdictions in regions other than USA.
Plasma Technologies Patents Technology for Increased
Yield of Plasma-derived AAT/IVIG Globally
It is apt if we refer to AAT as the key product of plasma-products industry that
is growing at about 10% annually and that already has $15 billion market.
AAT (alpha-1 antitrypsin) and IVIG (intravenous immune globulin) are
the most important of all plasma products as these are used in
treatment of several clinical conditions including Diabetes (type 1 & 2),
Alzheimer’s disease and Multiple Sclerosis. Besides that, AAT is also
administered in patients of genetic AAT deficiency disorder.

As such ,a solar cell cannot produce energy throughout the day. The international patent application of the Solar3D Solar Cell was filed
on February 20 and published on August 29, 2013 as announced at the World Intellectual Property Organization press release, in
Geneva, Switzerland recently.
Now, with this new and innovative technology, light management of solar cells will be as good as that of fiber optic devices. The 3-
dimensional design of Solar3D Cell will trap the sunlight inside micro-photovoltaic structures where photons will bounce around until
they are converted into electrons. An innovative wide-angle light collection feature on the cell surface will allow collection of sunlight
over a range of angles during the day.
A breakthrough 3-dimensional solar cell technology has been developed by Solar3D Inc. to maximize the electricity production from
sunlight. The main problem with conventional solar cells is that up to 30% of incident sunlight falling on them is reflected off the
surface and even more is lost inside the solar cell materials. As such,a solar cell cannot produce energy throughout the day. The
international patent application of the Solar3D Solar Cell was filed on February 20 and published on August 29, 2013 as announced at
the World Intellectual Property Organization press release, in Geneva, Switzerland recently.
Now, with this new and innovative technology, light management of solar cells will be as good as that of fiber optic devices. The 3-
dimensional design of Solar3D Cell will trap the sunlight inside micro-photovoltaic structures where photons will bounce around until
they are converted into electrons. An innovative wide-angle light collection feature on the cell surface will allow collection of sunlight
over a range of angles during the day.
E N E R G Y
International Patent Protection for 3-Dimensional Solar
Cell
A breakthrough 3-dimensional solar cell technology has been developed by
Solar3D Inc. to maximize the electricity production from sunlight.
A breakthrough 3-dimensional solar cell technology has been
developed by Solar3D Inc. to maximize the electricity production
from sunlight. The main problem with conventional solar cells is that
up to 30% of incident sunlight falling on them is reflected off the
surface and even more is lost inside the solar cell materials.
BMS to Defend Patent Dispute With BDR Pharma
Read: http://ow.ly/oTuhI
Breast Cancer & Trastuzumab Patent, An Article.
Read: http://ow.ly/oTunm
BIO-tract® Patented in 30+ Countries.
Read: http://ow.ly/oTutf
Drug Patent Reform Plans Please Activists.
Read: http://ow.ly/oTuwp

 Growing concern for environment
 Increased R&D investments in this sector
 Shifts in market conditions
 Enhanced opportunities to access profitable energy markets
 Emergence of new players specialized in wind technology, global equipment manufacturers, component suppliers
 Easy deployment
There is a perception that the commercial value of inventions & emerging technologies in wind energy sector will produce huge profits
for small, mid-size and large companies alike. These factors alongside others like meeting renewable energy targets and policy
incentives on using green energy sources have significantly contributed to the dramatic rise in patenting levels for wind.
Apart from these, for wind power, the rate of deployment (i.e. correlated with patenting growth considering that it takes several years
before a patent finds its way into the technology) goes hand-in-hand with the innovation and roughly one patent is granted for every
gigawatt (GW) of power installed. As such, the installed capacity of wind energy is predicted to triple in the next decade.
The wind energy sector was earlier limited to some niche applications but now many new players have emerged as wind technology
specialists, such as Denmark-based, Vestas, and Germany-based Enercon. Leading wind sector companies also include the global
equipment manufacturers such as General Electric (GE), Siemens and Mitsubishi. Even Component suppliers such as Hansen
International (gear-transmission systems) and ABB (electrical-distribution equipment) also feature herein.
Areas of Innovation in Wind Energy Sector
The changing focus of technological innovations and their subsequent relative growth can be measured by patent landscaping as in the
case of wind energy sector.
Till late 1990’s, three sub-spaces dominated the patent trends and the focus of innovation in wind sector was on these:
• Blades -that harnessed mechanical energy from the air
• Generator -for efficient conversion of mechanical energy into electricity
• Gearbox -that resulted in frequent breakdowns
In recent years, greater premium is on
• Effective integration with grid
• Accurate modelling of wind patterns
• Building in locations with high wind speeds
• Software and control systems,
• Short-term energy storage and
• Offshore technologies
Across the whole technology space there has been rise in trend towards larger-scale turbines. The largest wind turbines in the world are
stationed in Scotland and RePower own these 5 MW turbines with a 125m rotor diameter (larger than wingspan of an Airbus 380) and it
is expected that future offshore wind farms may have even larger unit sizes.
Rapidly Emerging Wind Energy Sector- Hub Spot of
IP-Related Matters
Nine-fold increase in wind patents since 1996.
In the past 2 decades, there has been a dramatic evolution in the
wind energy sector and it has emerged as a mainstream energy
source with a multi-billion-dollar market. Dramatic rise in
patenting levels for wind (nine-fold increase in wind patents since
1996) and superfluous growth in this sector (global installed wind
capacity reached 93,864 MW in 2008) is direct or indirect
consequence of the following factors-

Wind Energy Patent Ownership, Geographical Distribution & Key Markets
In the wind energy sector, the major patent holders are also the leading manufacturers. The top four wind patent owners collectively
owning 13% of all wind patents also own 48% share of the global wind turbine market.
As far as the geographical distribution of wind patents is concerned, leading locations of patent filing are United States and Japan
together with EU countries including the European Patent Office (EPO). Europe is both key wind market as well as a location of
inventive activity for this sector. The rapid rise of patent filings in China reflects its rising significance as a potential market and a
manufacturing location for both Chinese and multinational corporations. Market developments in both China and India are also
attracting significant investments by key technology owners in the space.
The majority of assignees are based in OECD countries viz. United States, Germany, Denmark and Japan. However, the rate of
patenting by China-based and Russia-based assignees is accelerating. The ultimate patent control usually lies with a bigger company’s
local subsidiaries. The top tier is dominated by OECD-based companies but non-OECD-based companies are climbing up the ranks
through mergers and acquisitions (M&A). Indian companies of OECD-based players in the wind industry have acquired many wind
energy companies and as such the proportion of wind energy patents controlled by India comes out to be much higher. Suzlon, an
Indian wind turbine manufacturer group has acquired many European technology companies like Hansen International.
Conclusion:
As wind energy industry expands, its knowledge assets become more valuable to market players. M&A are also increasing in this
industry and so are the patent concentration levels. In the emerging new innovation areas (software, offshore etc.), more M&A activity
can be anticipated by leading industry players who will be seeking higher market share.
Thus, we are going to witness more and more battles for attaining supremacy amongst the companies operating in this domain and
swelling up of more IP-related conflicts and aggressive IP-related business strategies. In the wind sector as the technology is maturing,
the numbers of both patent-related litigations and cross-licensing deals will also go up. One of the best-known patent lawsuit in the
wind sector concerns Enercon, which lost a patent lawsuit to Zond Energy Systems in the 1990’s.
Fracking King- Packer Plus Suing Competitors.
Read: http://ow.ly/oTuDX
USA’s Soaring Oil & Gas Industry Turning Into an Intellectual Property Battle Field.
Read: http://ow.ly/oTuJl
Rush For Oil Sector Patents in USA.
Read: http://ow.ly/oTuSR

Litigation
Support
Invalidity/
Opposition
Searches
Patents
Mining
Claim
Construction
Licensing
Support
Infringer
Identification
Claim/EoU
Charting
Reverse
Engineering
Prosecution
Support
Patentability/
Novelty
Searches
FTO/
Clearance
Searches
Patent
Illustrations/
Drawings
Patent Analytics
Patent
Landscape
Studies
Competition/
Technology
Watches
Structure/
Sequence
Searches
Paralegal
Support
Patent
Proofreading
IDS
Preparation
Patent
Docketing
Other Services
Global
Trademark
Searches
Design Searches
Patent
Translations
Prosecution
Watch
A B O U T S A G A C I O U S R E S E A R C H
Sagacious Research is an ISO Certified India based
Global Patent Research & Analytics firm offering
cost effective & multi-lingual Patent Searching, Patent
Licensing, Patent Alerts & Watches, Patent Drafting,
Trademark Searching & Design Searching Services in
over 100 countries and in over 16
Asian/European languages.
An ISO 9001:2008 and ISO 27001:2005
Certified Company
70+ Techno-legal Experts | 16+ Languages |
100 Countries | 5, 000+ Projects | 100%
Returning Clients
C O N T A C T S A G A C I O U S R E S E A R C H
Germany
Kathrin Reinhardt
+49 6107 6383 396
United Kingdom
Aarti Thakral
+44 (0) 203287 5098
Rest of Europe
Raphael Joseph
+353 125 49910
Australia
Steve Johnson
+61 3 9028 4017
United States
6387 Fairways Drive
Longmont, CO-80503
T: (303) 506-4192
F: (803) 831-1899
India (HQ)
303-B, Enkay Town Plaza, Block-I, Palam Vihar,
Gurgaon-122017, Delhi/NCR, India
T: +91 124 4033431
F: +91 11 43850700
Web:
info@sagaciousresearch.com
S E R V I C E S S A G A C I O U S R E S E A R C H
Litigation / Licensing Support
Services

Sagacious research newsletter-16th sep-2013

Recommended

Recommended

More Related Content

Recently uploaded

Recently uploaded (20)

Featured

Featured (20)

Sagacious research newsletter-16th sep-2013